Mechanisms of high-level ceftolozane/tazobactam resistance in Pseudomonas aeruginosa from a severely neutropenic patient and treatment success from synergy with tobramycin

被引：25
|
作者：
So, Wonhee [1 ]
Shurko, James [2 ,3 ]
Galega, Ralph [2 ,3 ]
Quilitz, Rod [1 ]
Greene, John N. [1 ]
Lee, Grace C. [2 ,3 ]
机构：
[1] H Lee Moffitt Canc Ctr & Res Inst, 12902 USF Magnolia Dr, Tampa, FL 33612 USA
[2] Univ Texas Austin, Coll Pharm, Austin, TX 78712 USA
[3] Univ Texas Hlth San Antonio, Sch Med, San Antonio, TX USA
来源：
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY | 2019年 / 74卷 / 01期
关键词：
TAZOBACTAM;
D O I：
10.1093/jac/dky393
中图分类号：
R51 [传染病];
学科分类号：
100401 ;
摘要：
引用
收藏
页码：269 / 271
页数：4
相关论文
共 43 条
  • [1] Ceftolozane-Tazobactam in the Treatment of Experimental Pseudomonas aeruginosa Pneumonia in Persistently Neutropenic Rabbits: Impact on Strains with Genetically Defined Mechanisms of Resistance
    Petraitis, Vidmantas
    Petraitiene, Ruta
    Naing, Ethan
    Aung, Thein
    Wai Phyo Thi
    Kavaliauskas, Povilas
    Maung, Bo Bo Win
    Michel, Adam O.
    Arbona, Rodolfo J. Ricart
    DeRyke, Andrew C.
    Culshaw, Darren L.
    Nicolau, David P.
    Satlin, Michael J.
    Walsh, Thomas J.
    [J]. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 2019, 63 (09)
  • [2] Ceftolozane/tazobactam for the treatment of multidrug resistant Pseudomonas aeruginosa: experience from the Balearic Islands
    Manuel Díaz-Cañestro
    Leonor Periañez
    Xavier Mulet
    M. Luisa Martin-Pena
    Pablo A. Fraile-Ribot
    Ignacio Ayestarán
    Asunción Colomar
    Belén Nuñez
    Maria Maciá
    Andrés Novo
    Vicente Torres
    Javier Asensio
    Carla López-Causapé
    Olga Delgado
    José Luis Pérez
    Javier Murillas
    Melchor Riera
    Antonio Oliver
    [J]. European Journal of Clinical Microbiology & Infectious Diseases, 2018, 37 : 2191 - 2200
  • [3] Ceftolozane/tazobactam for the treatment of multidrug resistant Pseudomonas aeruginosa: experience from the Balearic Islands
    Diaz-Canestro, Manuel
    Perianez, Leonor
    Mulet, Xavier
    Luisa Martin-Pena, M.
    Fraile-Ribot, Pablo A.
    Ayestaran, Ignacio
    Colomar, Asuncion
    Nunez, Belen
    Macia, Maria
    Novo, Andres
    Torres, Vicente
    Asensio, Javier
    Lopez-Causape, Carla
    Delgado, Olga
    Luis Perez, Jose
    Murillas, Javier
    Riera, Melchor
    Oliver, Antonio
    [J]. EUROPEAN JOURNAL OF CLINICAL MICROBIOLOGY & INFECTIOUS DISEASES, 2018, 37 (11) : 2191 - 2200
  • [4] Molecular mechanisms leading to ceftolozane/tazobactam resistance in clinical isolates of Pseudomonas aeruginosa from five Latin American countries
    Mojica, Maria F.
    De la Cadena, Elsa
    Rios, Rafael
    Carlos Garcia-Betancur, Juan
    Diaz, Lorena
    Reyes, Jinnethe
    Hernandez-Gomez, Cristhian
    Radice, Marcela
    Gales, Ana C.
    Castaneda Mendez, Paulo
    Munita, Jose M.
    Jose Pallares, Christian
    Martinez, Jose R. W.
    Virginia Villegas, Maria
    [J]. FRONTIERS IN MICROBIOLOGY, 2022, 13
  • [5] Mechanisms leading to in vivo ceftolozane/tazobactam resistance development during the treatment of infections caused by MDR Pseudomonas aeruginosa
    Fraile-Ribot, Pablo A.
    Cabot, Gabriel
    Mulet, Xavier
    Perianez, Leonor
    Martin-Pena, M. Luisa
    Juan, Carlos
    Perez, Jose L.
    Oliver, Antonio
    [J]. JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY, 2018, 73 (03) : 658 - 663
  • [6] Ceftolozane/tazobactam plus tobramycin against free-floating and biofilm bacteria of hypermutable Pseudomonas aeruginosa epidemic strains: Resistance mechanisms and synergistic activity
    Agyeman, Akosua A.
    Lopez-Causape, Carla
    Rogers, Kate E.
    Lucas, Deanna Deveson
    Cortes-Lara, Sara
    Gomis-Font, Maria A.
    Fraile-Ribot, Pablo
    Figuerola, Joan
    Lang, Yinzhi
    Franklyn, Eva R. T.
    Lee, Wee Leng
    Zhou, Jieqiang
    Zhang, Yongzhen
    Bulitta, Jurgen B.
    Boyce, John D.
    Nation, Roger L.
    Oliver, Antonio
    Landersdorfer, Cornelia B.
    [J]. INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS, 2023, 62 (03)
  • [7] Molecular Epidemiology and Mechanisms of High-Level Resistance to Meropenem and Imipenem in Pseudomonas aeruginosa
    Hassuna, Noha Anwar
    Darwish, Marwa K.
    Sayed, Mohamed
    Ibrahem, Reham Ali
    [J]. INFECTION AND DRUG RESISTANCE, 2020, 13 : 285 - 293
  • [8] Distinct epidemiology and resistance mechanisms affecting ceftolozane/tazobactam in Pseudomonas aeruginosa isolates recovered from ICU patients in Spain and Portugal depicted by WGS
    Hernandez-Garcia, Marta
    Garcia-Castillo, Maria
    Garcia-Fernandez, Sergio
    Melo-Cristino, Jose
    Pinto, Margarida F.
    Goncalves, Elsa
    Alves, Valquiria
    Vieira, Ana Raquel
    Ramalheira, Elmano
    Sancho, Luisa
    Diogo, Jose
    Ferreira, Rui
    Silva, Tania
    Chaves, Catarina
    Bou, German
    Cercenado, Emilia
    Delgado-Valverde, Mercedes
    Oliver, Antonio
    Pitart, Cristina
    Rodriguez-Lozano, Jesus
    Tormo, Nuria
    Romano, Joao
    Passaro, Leonor
    Paixao, Laura
    Lopez-Mendoza, Diego
    Diaz-Reganon, Jazmin
    Canton, Rafael
    [J]. JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY, 2021, 76 (02) : 370 - 379
  • [9] Genomic epidemiology and ceftazidime-avibactam high-level resistance mechanisms of Pseudomonas aeruginosa in China from 2010 to 2022
    Li, Xi
    Zhou, Longjie
    Lei, Tailong
    Zhang, Xiaofan
    Yao, Jiayao
    He, Jintao
    Liu, Haiyang
    Cai, Heng
    Ji, Jingshu
    Zhu, Yiwei
    Tu, Yuexing
    Yu, Yunsong
    Zhou, Hua
    [J]. EMERGING MICROBES & INFECTIONS, 2024, 13 (01)
  • [10] Phylogenetic analysis of resistance to ceftazidime/avibactam, ceftolozane/tazobactam and carbapenems in piperacillin/tazobactam-resistant Pseudomonas aeruginosa from cystic fibrosis patients
    Zamudio, Roxana
    Hijazi, Karolin
    Joshi, Chaitanya
    Aitken, Emma
    Oggioni, Marco R.
    Gould, Ian M.
    [J]. INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS, 2019, 53 (06) : 774 - 780
12345